C WorldWide Group’s PTC Therapeutics PTCT Stock Holding History

C WorldWide Group’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-158,686	Closed	-$1.56M	–	134
2017 Q1	$1.56M	Buy	158,686 +13,364	+9%	+$162K	0.03%	93
2016 Q4	$1.58M	Sell	145,322 -15,378	-10%	-$161K	0.03%	89
2016 Q3	$2.25M	Buy	160,700 +97,000	+152%	+$789K	0.04%	85
2016 Q2	$447K	Hold	63,700	–	–	0.01%	109
2016 Q1	$410K	Hold	63,700	–	–	0.01%	115
2015 Q4	$2.06M	Buy	+63,700	New	+$1.87M	0.04%	80

Other funds holding PTCT

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

C WorldWide Group's PTCT Position: Q2 2017 in Review

C WorldWide Group sold out of PTC Therapeutics (PTCT) in Q2 2017, closing a stake of 158,686 shares — an estimated $1.56M sold.

C WorldWide Group first reported a position in PTCT in Q4 2015 and held it in 6 quarters. The position peaked at $2.25M in Q3 2016. 114 funds tracked by Wall St. Rank hold PTCT as of Q2 2017.

C WorldWide Group reported no remaining PTC Therapeutics position as of Q2 2017 after selling out during the quarter.
C WorldWide Group sold 158,686 PTC Therapeutics shares in Q2 2017, an estimated $1.56M.
C WorldWide Group first reported a position in PTC Therapeutics in Q4 2015 and held it in 6 quarters.
C WorldWide Group's PTC Therapeutics position peaked at $2.25M in Q3 2016.
114 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2017.

Based on C WorldWide Group's 13F filing for Q2 2017, filed 2 Aug 2017.